We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Machine Learning Radically Reduces Workload of Cell Counting for Disease Diagnosis

By LabMedica International staff writers
Posted on 24 May 2022
Print article
Image: New training method allows machine learning to more accurately count blood cells (Photo courtesy of Pexels)
Image: New training method allows machine learning to more accurately count blood cells (Photo courtesy of Pexels)

Machine learning methods are increasingly spreading into the area of blood cell counting, until recently dominated by expensive and often less accurate traditional cell analyzers. However, due to the enormous amount of manual annotation work required, training the machine learning model has so far proven highly labor-intensive. Now, researchers have developed an innovative training method that automates much of this activity.

Researchers at Benihang University (Beijing, China) have developed the new scheme for training a convolutional neural network (CNN) - a type of machine learning that mirrors the connection structure of the human visual cortex. The number and type of cells in the blood often play a crucial role in disease diagnosis, but the cell analysis techniques commonly used to perform such counting of blood cells - involving the detection and measurement of physical and chemical characteristics of cells suspended in fluid - are expensive and require complex preparations. Worse still, the accuracy of cell analyzer machines is only about 90% due to various influences such as temperature, pH, voltage, and magnetic field that can confuse the equipment.

In order to improve accuracy, reduce complexity and lower costs, much research into alternatives has lately focused on the use of computer programs to perform “segmentation” on photographs of the blood taken by a high-definition camera connected to a microscope. Segmentation involves algorithms that perform pixel-by-pixel labeling of what appears in a photo, in this case, what parts of the image are cells and which are not - in essence, counting the number of cells in an image. For images in which only a single type of cell appears, such methods achieve a decent level of accuracy, but they perform poorly when confronting images with multiple types of cells. So in recent years, in attempts to solve the problem, researchers have turned to CNNs.

For the CNN to perform this task, it must first be “trained” to understand what is and is not a cell on many thousands of images of cells that humans have manually labeled. Then, when fed a novel, unlabelled image, it recognizes and can count the cells in it. The researchers at Beihang University developed a new scheme for training the CNN, in this case, U-Net, a fully convolutional network segmentation model that has been widely used in medical image segmentation since it was first developed in 2015. In the new training scheme, the CNN is first trained on a set of many thousands of images with only one type of cell (taken from the blood of mice).

These single-cell-type images are “preprocessed” automatically by conventional algorithms that reduce noise in the images, enhance their quality, and detect the contours of objects in the image. They then perform adaptive image segmentation. This latter algorithm calculates the various levels of gray in a black and white image, and if a part of the image lies beyond a certain threshold of gray, the algorithm segments that out as a distinct object. What makes the process adaptive is that rather than segmenting out parts of the image segments according to a fixed gray threshold, it does this according to the local features of the image.

After the single-cell-type training set is presented to the U-Net model, the model is fine-tuned using a small set of manually annotated images of multiple cell types. In comparison, a certain amount of manual annotation remains, and the number of images needed to be labeled by humans drops from what was previously many thousands to just 600. To test their training scheme, the researchers first used a traditional cell analyzer on the same mouse blood samples to do an independent cell count against which they could compare their new approach. They found that the accuracy of their training scheme on segmentation of multiple-cell-type images was 94.85%, which is the same level achieved by training with manually annotated multiple-cell-type images. The technique can also be applied to more advanced models to consider more complex segmentation problems. As the new training technique still involves some level of manual annotation, the researchers hope to go on to develop a fully automatic algorithm for annotating and training models.

Related Links:
Benihang University 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.